Baker Avenue Asset Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-46
Closed -$219 1607
2023
Q2
$219 Buy
+46
New +$219 ﹤0.01% 1548
2019
Q4
Sell
-20,000
Closed -$310K 260
2019
Q3
$310K Hold
20,000
0.02% 205
2019
Q2
$406K Hold
20,000
0.03% 186
2019
Q1
$351K Buy
+20,000
New +$351K 0.03% 207